Filip Janku, Chief Medical Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 9,189 shares at $19.50 ($179K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Open-market sale of $179k GLUE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GLUE | SELL | 2026-06-25 | $882K | — | Filing → |
| GLUE | SELL | 2026-01-05 | $48K | — | Filing → |